JM
Insider selling
John M. Evans sold $1.7M of BEAM stock
John M. Evans, CEO of Beam Therapeutics Inc. (BEAM), sold 50,000 shares of BEAM stock worth $1.7M, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 29, 2026, 2 days before it was made public.
BEAM has moved -29.7% since the trade date, from $34.95 to $24.56 (Oct 22, 2026 close).
- Traded
- Jun 29, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 2 days
- Price since
- -29.7%
- Role
- CEO
- Source
- SEC Form 4
More BEAM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.